{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1265812227", "close" : "1265835627", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}

Send us feedback. Tell us what you think about the new Article Page. Send us feedback

Research and Markets: Parkinson Disease Therapy Area Pipeline Report


businesswire
Press Release Source: Research and Markets On Friday November 27, 2009, 5:03 am EST

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4bfafd/parkinson_disease) has announced the addition of the "Parkinson Disease Therapy Area Pipeline Report" report to their offering.

Life Science Analytics, Parkinson Disease Therapy Area Pipeline Report contains detailed information on the parkinson disease drug pipeline. This report provides insight into the pipeline status of parkinson disease drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
  • Keep track of your competitors and partners by better understanding their product pipeline.
  • Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
  • Maintain a critical competitive advantage.

Key Topics Covered:

Epidemiology Report
% of Products by Phase of Development
No. of Products by Phase of Development
Marketed Products vs. Pipeline Products
Company Overview - Pipeline Projects
Legend
Patent Expirations
Upcoming Milestones
Product Sales
Full Pipeline View
News Updates

For more information visit http://www.researchandmarkets.com/research/4bfafd/parkinson_disease

Source: Life Science Analytics

Contact:

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sponsored Links

Copyright © 2010 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials by posting, archiving in a public web site or database, or redistribution in a computer network is strictly forbidden.